ArticleMolecular biology reports2026
Vitamin D receptor (ApaI/BsmI) polymorphisms, human leukocyte antigen-DQB2/DRB3 sub-alleles, and endoplasmic reticulum stress: unravelling their interplay in the pathogenesis of Graves' disease in a tertiary care centre.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAutoimmune thyroid diseases (AITDs), particularly Graves’ disease (GD), are complex disorders characterized by thyroidal immune infiltration and autoantibody production influenced by genetic and environmental factors. HLA class II alleles (HLA-DQB2, HLA-DRB3) promote immune tolerance loss via altered antigen presentation, while vitamin D receptor (VDR) polymorphisms (ApaI-rs7975232; BsmI-rs1544410) disrupt immune homeostasis by affecting VDR signaling and Treg/Th1/Th2/Th17 balance. Furthermore, chronic endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) exacerbate inflammation, apoptosis and defective TSHR signaling. This study explores the indirect mechanistic association and coordinated signaling pathways among VDR polymorphisms, ER stress markers, and HLA class II alleles, revealing integrated mechanisms underlying GD pathogenesis. METHODS AND
resultsA cohort of 70 Graves’ disease patients and age-sex matched healthy controls were analyzed for genetic, molecular and biochemical parameters related to Graves’ hyperthyroidism. PBMCs, RNA, DNA and proteins were extracted for qRT-PCR, immunoblotting, and PCR-RFLP genotyping (VDR rs7975232, rs1544410) following standardized, ethically approved protocols. Graves’ disease (GD) patients, predominantly female, exhibited vitamin D deficiency without significant serum variation. VDR polymorphisms (ApaI, BsmI) were detected in 65.71% and 64.28% of patients respectively, correlating with heightened thyroid hormone levels, autoantibody titres, proinflammatory cytokines, ER stress and reduced FoxP3/CTLA-4 expression. HLA-DQB2 and HLA-DRB3 sub-alleles further indicated strong genetic susceptibility to GD pathogenesis.
conclusionThis study demonstrates that VDR polymorphisms (ApaI, BsmI) exacerbate Graves’ disease by enhancing thyroid autoimmunity, inflammation and ER stress while diminishing immune tolerance. Despite comparable vitamin D levels, VDR-mutant patients exhibited heightened immune activation. HLA class II alleles influence susceptibility, whereas VDR variants dictate disease severity, underscoring VDR signaling as a therapeutic target.
Indexed as
Identifiers
41989523What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.